Court sides with Te­va over Emer­gent in gener­ic Nar­can suit

Te­va Phar­ma­ceu­ti­cals is fac­ing a dif­fi­cult road ahead, thanks to 3,500 cas­es of lit­i­ga­tion sur­round­ing its role in the US opi­oid epi­dem­ic. But the man­u­fac­tur­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER